Condition
Tumor Infiltrating Lymphocytes clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Tumor Infiltrating Lymphocytes clinical trials that are recruiting, in China. By phase: Early Phase 1 (3), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Tumor Infiltrating Lymphocytes clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| PD-1–edited tumor-infiltrating T cells for advanced colorectal cancer | Phase 1 | Shanghai, None Selected | Recruiting | Jun 24, 2025 |
| GC203 tumor-infiltrating lymphocyte therapy for pancreatic ductal adenocarcinoma | Early Phase 1 | Shanghai, Shanghai Municipality | Recruiting | Feb 14, 2025 |
| Using tumor infiltrating lymphocytes to treat advanced solid tumors | Early Phase 1 | Shanghai | Recruiting | Jul 5, 2024 |
| Using tumor infiltrating lymphocytes to treat advanced solid tumors | Early Phase 1 | Hangzhou, Zhejiang | Recruiting | Oct 21, 2021 |
All recruiting trials (4)
-
PD-1–edited tumor-infiltrating T cells for advanced colorectal cancer
This test uses a patient's own tumor-infiltrating T cells, edited to remove PD‑1, to see if the treatment is safe and may help adults with advanced colorectal cancer who no longer have standard treatment options.
-
GC203 tumor-infiltrating lymphocyte therapy for pancreatic ductal adenocarcinoma
This trial will test whether gene-edited tumor-infiltrating lymphocytes (GC203 TIL), given after mild lymphodepletion, are safe and can help people with pancreatic ductal adenocarcinoma who have not responded to standard treatments.
-
Using tumor infiltrating lymphocytes to treat advanced solid tumors
This study is testing a new treatment using specially modified immune cells from tumors to see if it can help people with advanced solid tumors feel better.
-
Using tumor infiltrating lymphocytes to treat advanced solid tumors
This study is testing a new treatment using immune cells from patients' own tumors to see if it can help people with advanced solid tumors who haven't responded to other therapies.
Related topics
Quick answers
How many Tumor Infiltrating Lymphocytes clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.